Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Rutgers

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Patient Education and Counseling|November 14, 1997
Genetic counseling for hereditary cancer: a pilot study on experiences of patients and family membersE M Bleiker, N K Aaronson, F H Menko, et al.
Breast Cancer Research and Treatment|September 23, 2008
The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort studyK E Pengel, C E Loo, H J Teertstra, et al.
Annals of Surgical Oncology|April 21, 2001
Frozen section investigation of the sentinel node in malignant melanoma and breast cancerP J Tanis, R P Boom, H S Koops, et al.
Familial Cancer|October 24, 2003
MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC)M Kriege, C T Brekelmans, C Boetes, et al.
Breast Cancer Research and Treatment|March 24, 2016
Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year periodS C J Bosma, F van der Leij, E van Werkhoven, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysisE van der Wall, C C Schaake-Koning, N van Zandwijk, et al.
American Journal of Human Genetics|March 21, 2000
ATM-heterozygous germline mutations contribute to breast cancer-susceptibilityA Broeks, J H Urbanus, A N Floore, et al.
Cancer|June 22, 2000
Lymphatic mapping with intralesional tracer administration in breast carcinoma patientsM H Doting, L Jansen, O E Nieweg, et al.
British Journal of Cancer|April 1, 1995
High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approachE van der Wall, W J Nooijen, J W Baars, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST)A C Voogd, J L Peterse, M A Crommelin, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Patient Education and Counseling|November 14, 1997
Genetic counseling for hereditary cancer: a pilot study on experiences of patients and family membersE M Bleiker, N K Aaronson, F H Menko, et al.
Breast Cancer Research and Treatment|September 23, 2008
The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort studyK E Pengel, C E Loo, H J Teertstra, et al.
Annals of Surgical Oncology|April 21, 2001
Frozen section investigation of the sentinel node in malignant melanoma and breast cancerP J Tanis, R P Boom, H S Koops, et al.
Familial Cancer|October 24, 2003
MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC)M Kriege, C T Brekelmans, C Boetes, et al.
Breast Cancer Research and Treatment|March 24, 2016
Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year periodS C J Bosma, F van der Leij, E van Werkhoven, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysisE van der Wall, C C Schaake-Koning, N van Zandwijk, et al.
American Journal of Human Genetics|March 21, 2000
ATM-heterozygous germline mutations contribute to breast cancer-susceptibilityA Broeks, J H Urbanus, A N Floore, et al.
Cancer|June 22, 2000
Lymphatic mapping with intralesional tracer administration in breast carcinoma patientsM H Doting, L Jansen, O E Nieweg, et al.
British Journal of Cancer|April 1, 1995
High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approachE van der Wall, W J Nooijen, J W Baars, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST)A C Voogd, J L Peterse, M A Crommelin, et al.
Pageof 8